Evidence map›Paper›PMID 33682322›Full record

ArticleJournal of cellular and molecular medicine2021

Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells-Not acinar cells.

Simon Trapp, Ali A Aghdassi, Juliane Glaubitz, Matthias Sendler, Frank Ulrich Weiss, Jens Peter Kühn, Marie-Luise Kromrey, Ujjwal M Mahajan, Petra Pallagi, Zoltán Rakonczay and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Simon TrappDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Ali A AghdassiDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-0569-7316
Juliane GlaubitzDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Matthias SendlerDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Frank Ulrich WeissDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Jens Peter KühnInstitute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
Marie-Luise KromreyInstitute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
Ujjwal M MahajanDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Petra PallagiFirst Department of Medicine, University of Szeged, Szeged, Hungary.
Zoltán RakonczayDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
Viktória VengloveczDepartment of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
Markus M LerchDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Peter HegyiDepartment of Translational Medicine/First Department of Medicine, Medical School, Institute for Translational Medicine, Pécs, Hungary.
Julia MayerleDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Universitätsmedizin Greifswald · DEUniversity of Szeged · HU

Funding

Deutsche Forschungsgemeinschaft AG 203/2-1/4-1Deutsche Forschungsgemeinschaft GRK 1947;A3Deutsche Forschungsgemeinschaft MA 4115/1-2/3Deutsche Forschungsgemeinschaft SE 2702/2-1EnErGie/P2 Project ESF/14-BM-A55-0008/18European Union V-630-S-150-2012/132/133Federal Ministry of Education and Research 01ZZ0103Federal Ministry of Education and Research 01ZZ0403Federal Ministry of Education and Research 01ZZ9603Federal Ministry of Education and Research 0314107Federal Ministry of Education and Research 03IS2061AFederal Ministry of Education and Research 03ZIK012Federal Ministry of Education and Research 03zz0921EFederal Ministry of Education and Research 03ZZ0921EPePPP centre of excellence MV ESF/14-BM-A55-0045/16
6 · The paper itself

Abstract

Mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) are an established risk factor for cystic fibrosis (CF) and chronic pancreatitis. Whereas patients with CF usually develop complete exocrine pancreatic insufficiency, pancreatitis patients with CFTR mutations have mostly preserved exocrine pancreatic function. We therefore used a strain of transgenic mice with significant residual CFTR function (CFTR

Indexed as

MutationAcinar CellsAnimalsChloridesCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansInflammationMaleMiceMice, TransgenicPancreatic DuctsPancreatitisSeverity of Illness IndexCFTR protein, humanChloridesCystic Fibrosis Transmembrane Conductance Regulatoracute pancreatitisCFTRductal cellsinflammatory cells

Identifiers

PMID33682322
PMCPMC8107082
OpenAlexW3134158281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.